Published in PLoS One on May 20, 2015
Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Infect Dis Poverty (2015) 0.83
Evaluation of a liquid culture system in the detection of mycobacteria at an antituberculosis institution in China; A retrospective study. J Int Med Res (2016) 0.81
Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals. PLoS One (2015) 0.78
Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health (2017) 0.75
Early appraisal of China's huge and complex health-care reforms. Lancet (2012) 7.71
Progress in tuberculosis control and the evolving public-health system in China. Lancet (2007) 4.86
Equity in health and health care: the Chinese experience. Soc Sci Med (1999) 2.42
Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis (2014) 2.40
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res (2009) 2.07
Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health (2007) 1.95
Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health (2011) 1.73
Perceptions and experiences of health care seeking and access to TB care--a qualitative study in rural Jiangsu Province, China. Health Policy (2004) 1.71
Perception and social consequences of tuberculosis: a focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med (1995) 1.64
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med (2013) 1.61
How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Trop Med Int Health (2007) 1.57
Perceptions of tuberculosis and health seeking behaviour in rural Inner Mongolia, China. Health Policy (2006) 1.54
Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Trop Med Int Health (2009) 1.53
Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review. BMC Public Health (2012) 1.52
DOTS in China - removing barriers or moving barriers? Health Policy Plan (2006) 1.44
Revenue-driven in TB control--three cases in China. Int J Health Plann Manage (2005) 1.37
Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study. Trop Med Int Health (2009) 1.35
Patients are paying too much for tuberculosis: a direct cost-burden evaluation in Burkina Faso. PLoS One (2013) 1.31
China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One (2014) 1.14
[Tuberculosis and socioeconomic indicators: systematic review of the literature]. Rev Panam Salud Publica (2013) 1.13
Epidemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead. BMC Public Health (2011) 1.12
Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China. BMC Infect Dis (2013) 1.08
Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials (2013) 1.06
Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health (2008) 1.03
Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study. PLoS One (2013) 1.02
Multidrug-resistant tuberculosis around the world: what progress has been made? Eur Respir J (2014) 1.01
Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Public Health (2009) 0.99
Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China. Int J Tuberc Lung Dis (2013) 0.98
Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China. PLoS One (2014) 0.98
Tuberculosis control in China: striving for sustainability. Lancet (2012) 0.87
Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics. Glob Health Action (2014) 0.86
Economic impact of pulmonary tuberculosis on patients and their families of Dharan municipality, Nepal. Nepal Med Coll J (2012) 0.84
Factors affecting patient delay of diagnosis and completion of Direct Observation Therapy, Short-course (DOTS) among the migrant population in Shandong, China. Biosci Trends (2013) 0.83
Perspectives on tuberculosis among traditional Chinese medical practitioners in New York City's Chinatown. Cult Med Psychiatry (2006) 0.83
Effective reimbursement rates of the rural health insurance among uncomplicated tuberculosis patients in China. Trop Med Int Health (2014) 0.82
A sustainable agenda for tuberculosis control and research. Lancet (2012) 0.82
Why India should become a global leader in high-quality, affordable TB diagnostics. Indian J Med Res (2012) 0.81
Can hospitalization provide better compliance in smear positive tuberculosis patients? Tuberk Toraks (2009) 0.80
A systematic review of maggot debridement therapy for chronically infected wounds and ulcers. Int J Infect Dis (2014) 0.84
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial. J Gastroenterol Hepatol (2016) 0.77